These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2716216)

  • 1. Natural killer cell activity and recycling capacity of natural killer cells in patients with carcinoma of the prostate.
    Marumo K; Ikeuchi K; Baba S; Ueno M; Tazaki H
    Keio J Med; 1989 Mar; 38(1):27-35. PubMed ID: 2716216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
    Steinhauer EH; Doyle AT; Reed J; Kadish AS
    J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the mechanism of defective natural killer cytotoxicity in patients with multiple myeloma].
    Funato T; Koide A; Ohtani H; Saito M
    Gan No Rinsho; 1984 Apr; 30(4):368-72. PubMed ID: 6727037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired natural killer cell recycling in childhood chronic neutropenia with morphological abnormalities and defective chemotaxis of neutrophils.
    Komiyama A; Kawai H; Yamada S; Aoyama K; Yamazaki M; Saitoh H; Miyagawa Y; Akabane T; Uehara Y
    Blood; 1985 Jul; 66(1):99-105. PubMed ID: 3873972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Natural killer cell activity in Naegleria fowleri infected mice].
    Lee KR; Shin CO; Im K
    Kisaengchunghak Chapchi; 1991 Sep; 29(3):267-77. PubMed ID: 1786253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natural killer cell activity in mice infected with Acanthamoeba culbertsoni].
    Hyun DK; Shin CO; Im K
    Kisaengchunghak Chapchi; 1992 Jun; 30(2):101-12. PubMed ID: 1627498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional properties of natural killer cells in carcinoma of the prostate.
    Wirth M; Schmitz-Dräger BJ; Ackermann R
    J Urol; 1985 Jun; 133(6):973-8. PubMed ID: 3999223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of responsiveness to interferon-gamma but not to interleukin 2 and depressed recycling as natural killer cell abnormalities in childhood lymphohistiocytic syndrome.
    Yang FC; Yabuhara A; Koike K
    Int J Hematol; 1994 Jun; 59(4):273-80. PubMed ID: 8086621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell activity in patients with prostatic carcinoma and its in vivo boosting with bacillus Calmette-Guérin.
    Schwemmer B; Lehmer A; Hofmann R; Braun J
    Urol Int; 1984; 39(6):321-6. PubMed ID: 6523641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of effector cells responsible for cell-mediated cytotoxicity in patients with carcinoma of the prostate.
    Ackermann R; Wirth M; Hasler L; Okabe T
    Urol Int; 1981; 36(1):46-52. PubMed ID: 6973229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell activity of prostatic cancer patients.
    Choe BK; Frost P; Morrison MK; Rose NR
    Cancer Invest; 1987; 5(4):285-91. PubMed ID: 2444316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
    Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
    Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional abnormalities of natural killer cells in childhood hemophagocytic syndrome].
    Yang FC; Yabuhara A; Koike K; Komiyama A
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Feb; 18(1):36-44. PubMed ID: 7553037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-induced NK augmentation in humans. An analysis of target recognition, effector cell recruitment and effector cell recycling.
    Ullberg M; Merrill J; Jondal M
    Scand J Immunol; 1981 Sep; 14(3):285-92. PubMed ID: 6173918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
    Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recycling and target binding capacity of human natural killer cells.
    Ullberg M; Jondal M
    J Exp Med; 1981 Mar; 153(3):615-28. PubMed ID: 7252409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus.
    Yabuhara A; Yang FC; Nakazawa T; Iwasaki Y; Mori T; Koike K; Kawai H; Komiyama A
    J Rheumatol; 1996 Jan; 23(1):171-7. PubMed ID: 8838528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable natural killer function of tumour-infiltrating lymphocytes from breast carcinomas.
    Gudmundsdóttir I; Ogmundsdóttir HM
    APMIS; 1992 Aug; 100(8):737-46. PubMed ID: 1325805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more efficient.
    Vidaller A; Guadarrama F; Llorente L; Méndez JB; Larrea F; Villa AR; Alarcón-Segovia D
    J Clin Immunol; 1992 May; 12(3):210-5. PubMed ID: 1400902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.